Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions
Planning for potential discomfort during this phase increases success probability
Comprehensive Meal Ideas: Covers light breakfasts, satisfying lunches, quick dinners, and smart snacks
Curious About Medically Supervised Weight Loss
Some researchers have highlighted post-treatment study findings that have shown that people tend to suffer from a high risk of weight regain after stopping these drugs
It is not intended for human therapeutic, diagnostic, or clinical use.